ARCHIVES

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

This article is from The Cancer Letter archive.

Vol. 20 No. 41 | October 28, 1994

Download PDF Visit The Full Archive

Related Articles

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

June 13, 1980

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

PET Tracer Drug Approved, Developed At Weill Cornell

September 24, 2004

Cancer Clinical Trials Approved By NCI Last Month Are Listed

October 25, 2002

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975

Report On Carcinogenesis Testing, Evaluation Submitted to NTP; Calls For Continued Research

September 7, 1984